Viewing Study NCT06441383



Ignite Creation Date: 2024-06-16 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06441383
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-07
First Post: 2024-05-28

Brief Title: Assessment of Sleep Disordersin People Living With HIV in the Era of New Antiretroviral Therapies in North of France
Sponsor: Tourcoing Hospital
Organization: Tourcoing Hospital

Study Overview

Official Title: Assessment of Sleep Disordersin People Living With HIV in the Era of New Antiretroviral Therapies in North of France
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SANDMAN
Brief Summary: People living with HIV PLHIV appear to present with sleep-related complaints more frequently than the general population with a prevalence of 50-70 The latest French multi-center epidemiological data are dated The prevalence of the different types of sleep disorders however is poorly documented with the literature focusing mainly on insomnia and neuropsychological disorders that can lead to sleep disorder-like symptoms and on the impact of antiretroviral drugs in particular However there are other sleep disorders such as sleep apnea syndrome SAHOS or restless legs syndrome SAHOS has been studied in small series of patients

This multicenter cross-sectional study will identify and update the functional complaints presented by PLHIV estimate the prevalence of people at high risk of sleep apnea syndrome and study the associated socio-demographic factors in relation to HIV infection and antiretrovirals This study could open up avenues for new management approaches and earlier detection of sleep disorders
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None